AMPYRA

Acorda loses its last shot at protecting its cash cow franchise drug. It’s up to Inbrija now
Endpoints
Mon, 10/7/19 - 11:08 am
Acorda Therapeutics
AMPYRA
multiple sclerosis
Supreme Court
Federal court rules Ampyra patents invalid, Acorda stock sinks 25%
Biopharma Dive
Mon, 09/10/18 - 11:54 pm
Acorda Therapeutics
MS
multiple sclerosis
AMPYRA
patents
Acorda looks to Inbrija launch as Ampyra court battle continues
Biopharma Dive
Fri, 08/3/18 - 10:59 pm
Acorda Therapeutics
Inbrija
AMPYRA
Here's Why Acorda Therapeutics Rose as Much as 30.3% Today
Motley Fool
Fri, 06/8/18 - 11:36 pm
Acorda Therapeutics
AMPYRA
patents
CEO: Win or lose on Ampyra patents, Acorda reps are safe with Parkinson's prospect
Fierce Pharma
Wed, 06/6/18 - 11:33 am
drug reps
layoffs
Acorda Therapeutics
AMPYRA
generics
Bass Battled U.S. Drug Patents and Prices But Lost to ‘Cabal’
Bloomberg
Mon, 04/10/17 - 10:06 am
Kyle Bass
patents
drug pricing
AMPYRA
Acorda Therapeutics
multiple sclerosis
Acorda is shifting into survival mode. And it’s going to start by axing more than 100 staffers.
Endpoints
Wed, 04/5/17 - 12:05 pm
Acorda Therapeutics
layoffs
AMPYRA
Patent decision puts 95% of Acorda revenue at risk
BioPharma Dive
Tue, 04/4/17 - 07:23 pm
Acorda Therapeutics
patents
AMPYRA
multiple sclerosis
MS
Trial miss derails Acorda's Ampyra plans
BioPharma Dive
Tue, 11/22/16 - 11:37 am
Acorda Therapeutics
AMPYRA
stroke
Acorda Stroke Study Fails, Dampening Revenue Growth Plans
TheStreet.com
Mon, 11/21/16 - 11:28 am
Acorda Therapeutics
AMPYRA
stroke
Hedge fund manager Kyle Bass loses first challenges to pharma patents
Yahoo/Reuters
Tue, 08/25/15 - 08:37 am
patents
AMPYRA
Kyle Bass
Acorda Therapeutics
MS
multiple sclerosis
Acorda Drug Helps Stroke Patients Walk Better
TheStreet.com
Mon, 04/15/13 - 08:50 am
Acorda
AMPYRA
stroke
Potentially game changing data awaits Acorda in 2013
Reuters
Fri, 12/21/12 - 10:42 am
Acorda Therapeutics
AMPYRA
stroke
Acorda sinks after insurance provider questions MS drug
Yahoo/Fly on the Wall
Mon, 10/8/12 - 12:13 pm
Acorda
MS
multiple sclerosis
AMPYRA
Acorda: Volatility Expected On Upcoming Trial Results For Lower Ampyra Dose
Yahoo/Reuters
Mon, 08/6/12 - 11:11 am
AMPYRA
Acorda
Acorda Therapeutics To FDA: What Deadlines?
Pharmalot
Thu, 05/17/12 - 10:23 am
FDA
Acorda Therapeutics
adverse events
AMPYRA
5 Biotech Drug-Launch Stocks to Watch
TheStreet.com
Mon, 07/18/11 - 10:03 am
Human Genome Sciences
Vertex Pharmaceuticals
Acorda Therapeutics
Dendreon
Avanir
lupus
Benlysta
Incivek
hepatitis C
MS
AMPYRA
Provenge
prostate cancer
Nuedexta
PBA
Acorda Pushes Sales of MS Drug
Minyanville
Wed, 06/29/11 - 12:07 am
Acorda Therapeutics
MS
multiple sclerosis
AMPYRA
Analyst raises Acorda target as Ampyra sales grow
Yahoo/AP
Mon, 06/13/11 - 06:11 pm
AMPYRA
Acorda Therapeutics
MS
Biogen Idec
multiple sclerosis
Acorda’s Ampyra Runs Ahead of Other MS Treatments
Minyanville
Wed, 04/14/10 - 01:56 pm
MS
Acorda Therapeutics
AMPYRA
multiple sclerosis

Pages